“…Enzalutamide, Apalutamide (A587V, F876L, F877L, G684A, K631T, L595M, Q920R, R630Q, T576A, T878A) [46,47] Darolutamide (A587V) [48] Darolutamide (F876L, F877L, W742L, T787A, W741L, T878A, L702H, H875Y) [48] Galaterone (F877L, T878A) [49] TRC253 (F877L) [50,51]. ARV-110 [52,53] ARCC-4 [54] * Clinical benefit/resistance proven in clinical trials.…”